Biotech

Tim Boreham interviews Anatara CEO Steven Lydeamore for Dr Boreham's Crucible

🕔9/2/2019 10:21:31 AM

Anatara Lifesciences (ASX:ANR) CEO Steve Lydeamore recently spoke with experienced business writer, Tim Boreham, for his Dr Boreham's Crucible column which was published in Biotech Daily on Friday night and then reproduced in Stockhead across the weekend.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Message from the CEO

🕔8/30/2019 1:12:03 PM

The 2018-2019 year has been a year of transition for Anatara Lifesciences (ASX:ANR), having commenced the year with a clear focus on successfully evolving into a human health company, through the pursuit of the burgeoning gastrointestinal health market.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) 2019 Financial Report

🕔8/27/2019 9:46:10 AM

Anatara Lifesciences (ASX:ANR) today released its Appendix 4E and review of operations for the period ending 30th June 2019.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation

🕔8/23/2019 8:15:53 AM

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, presented at the Monsoon Communications Twilight Investor Briefing, yesterday evening, in Melbourne.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Live Investor Briefing

🕔8/16/2019 9:06:24 AM

Anatara Lifesciences Ltd's (ASX:ANR) CEO, Steve Lydeamore will be presenting to investors at a Monsoon Communications Twilight Investor Briefing event in Melbourne next week. Investors interested in attending this presentation are invited to reach out.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Animal Health Assets Update

🕔8/5/2019 9:22:28 AM

Anatara Lifesciences (ASX:ANR) provides an update on the strategic evaluation of Detach(R), its non-antibiotic animal health asset which aids in the control of diarrhoeal disease in piglets (known as scour), with potential application in other livestock animals, aquaculture and companion animals.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation

🕔7/29/2019 8:16:02 AM

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, presented at the 15th Bioshares Biotech Summit, held in Queenstown, New Zealand, 26th to 27th July 2019.

Read Full Article